Completing the Arc: Targeted Inhibition of RET in Medullary Thyroid Cancer

被引：16
|
作者：
Houvras, Yariv [1 ,2 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] New York Presbyterian Hosp, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 02期
关键词：
MUTATIONS; CARCINOMAS; VANDETANIB; GENETICS; DISEASE; ZD6474;
D O I：
10.1200/JCO.2011.38.7639
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 202
页数：3
相关论文
共 50 条
  • [21] Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series
    Contrera, Kevin J.
    Gule-Monroe, Maria K.
    Hu, Mimi I.
    Cabanillas, Maria E.
    Busaidy, Naifa L.
    Dadu, Ramona
    Waguespack, Steven G.
    Wang, Jennifer R.
    Maniakas, Anastasios
    Lai, Stephen Y.
    Diersing, Julia
    Kwon, Michael
    Grubbs, Elizabeth G.
    Subbiah, Vivek
    Williams, Michelle D.
    Zafereo, Mark E.
    THYROID, 2023, 33 (01) : 129 - 132
  • [22] The rate of RET mutation testing in medullary thyroid cancer in the Republic of Ireland
    Malone, Eoghan Ruadh
    Gallagher, David James
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib
    Hong, David
    Ye, Lei
    Gagel, Robert
    Chintala, Lakshmi
    El Naggar, Adel K.
    Wright, John
    Kurzirock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (05) : 1001 - 1006
  • [24] RET PROTOONCOGENE MUTATIONS IN INHERITED AND SPORADIC MEDULLARY-THYROID CANCER
    BLAUGRUND, JE
    JOHNS, MM
    EBY, YJ
    BALL, DW
    BAYLIN, SB
    HRUBAN, RH
    SIDRANSKY, D
    HUMAN MOLECULAR GENETICS, 1994, 3 (10) : 1895 - 1897
  • [25] Prophylactic Thyroidectomy in RET Carriers at Risk for Hereditary Medullary Thyroid Cancer
    Machens, Andreas
    Dralle, Henning
    THYROID, 2009, 19 (06) : 551 - 554
  • [26] The role of RET genotypes as modifier loci for sporadic medullary thyroid cancer
    Muzza, M.
    Mian, C.
    Cordella, D.
    Barollo, S.
    Alberti, L.
    Cirello, V.
    Dazzi, D.
    Girelli, M. E.
    Opocher, G.
    Beck-Peccoz, P.
    Persani, L.
    Fugazzola, L.
    HORMONE RESEARCH, 2007, 68 : 34 - 34
  • [27] Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells
    Gild, Matti L.
    Landa, Inigo
    Ryder, Mabel
    Ghossein, Ronald A.
    Knauf, Jeffrey A.
    Fagin, James A.
    ENDOCRINE-RELATED CANCER, 2013, 20 (05) : 659 - 667
  • [28] RET genetic screening in patients with medullary thyroid cancer: The Moroccan experience
    Abdelhakim, Ainahi
    Anne, Barlier
    Mohamed, Kebbou
    Nadia, Benabdeljalil
    Mohammed, Timinouni
    Taoufiq, Fechtali
    Catherine, Roche
    Said, El Antri
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2009, 5 (03) : 198 - 202
  • [29] RET screening uncovers hidden cases of hereditary medullary thyroid cancer
    Carol Wilson
    Nature Reviews Endocrinology, 2011, 7 (2) : 63 - 63
  • [30] Progress in Molecular Targeted Therapy for Thyroid Cancer: Vandetanib in Medullary Thyroid Cancer
    Solomon, Benjamin
    Rischin, Danny
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (02) : 119 - 121
12345